Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD
This clinical trial update investigates using exhaled breath analysis with eNose technology as a biomarker for diagnosing and monitoring pro…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
A UCLA-led clinical study evaluating whether a single time-point prediction can enable earlier diagnosis of progressive pulmonary fibrosis, …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Interstitial Lung Disease Exacerbations Study
Clinical trial update for an interstitial lung disease/exacerbations study sponsored by Royal Devon and Exeter NHS Foundation Trust. The tri…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis
This completed clinical trial evaluates metabolomic biomarkers in pulmonary fibrosis; no results on treatments or efficacy are provided in t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
An ongoing clinical trial by Paragonix Technologies aims to create a global registry to improve donor lung preservation. Enrollment is by in…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital [Phase 3]
A Phase 3 clinical trial evaluating safety and effectiveness of cyclosporin for managing COVID-19 acute respiratory distress syndrome has co…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
A clinical study evaluating end-expiratory trans-pulmonary pressure guided PEEP titration in mechanically ventilated patients with idiopathi…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline [Phase 2]
A Phase 2 trial led by Makerere University is investigating doxycycline to characterize and prevent tuberculosis-associated lung fibrosis an…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Pulmonary Fibrosis Foundation Community Registry
The Pulmonary Fibrosis Foundation Community Registry trial (NCT05382572) is currently recruiting. It aims to collect data on patients with p…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.
A proof-of-concept study is evaluating inhaled targeted imatinib nan formulations for pulmonary arterial hypertension and pulmonary fibrosis…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis [NA]
A completed clinical trial comparing pulmonary telerehabilitation to standard physical activity recommendations in patients with post-COVID …
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease [NA]
This clinical trial update covers a randomized study of a digital self-management package for people with interstitial lung disease, current…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: P4O2 ILD Extension
A clinical trial update describes an extension of the P4O2 interstitial lung disease study led by Amsterdam UMC (VUmc) and currently recruit…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Non-pharmacological Cough Control Therapy [NA]
This clinical trial update reports a non-pharmacological cough control therapy being studied for cough in interstitial lung disease and pulm…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
A recruiting clinical trial aims to identify multiple pulmonary diseases by using volatile organic compound biomarkers in exhaled breath.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Advancing Prevention of Pulmonary Fibrosis
This update covers an ongoing University of Colorado, Denver clinical trial focused on preventing pulmonary fibrosis, including idiopathic p…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 [Phase 1]
A Phase 1 trial evaluating the imaging agent 68Ga-FAP-2286 for pathologic fibrosis in liver, lung, and heart has completed its Phase 1 study…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device [NA]
A completed clinical trial in people with pulmonary fibrosis to monitor cough using a wearable device; results have been posted.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC [NA]
This clinical trial update describes a study on using artificial intelligence in a pulmonary fibrosis clinic, with the trial listed as not y…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating BMS-986278 in patients with pulmonary fibrosis has completed, and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 [Phase 4]
Phase 4 study evaluating nintedanib for slowing lung disease in patients with fibrotic or non-fibrotic interstitial lung disease related to …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis [NA]
A clinical trial update indicates a study evaluating transbronchial cryobiopsy for diagnosing progressive pulmonary fibrosis, currently recr…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Rehabilitation Counselling for Patients with Interstitial Lung Disease
This clinical trial update notes that the study 'Rehabilitation Counselling for Patients with Interstitial Lung Disease' is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma [Phase 2, Phase 3]
Phase 2/3 trials evaluated the efficacy and safety of oral bosentan for pulmonary fibrosis associated with systemic sclerosis, and the studi…